Report Details

Tables and Figures
List of Tables
Table 1. Global Prostate Cancer Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Prostate Cancer Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Prostate Cancer Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Prostate Cancer Vaccines Market Competitive Situation by Manufacturers in 2021
Table 5. Global Prostate Cancer Vaccines Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Prostate Cancer Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Prostate Cancer Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Prostate Cancer Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Prostate Cancer Vaccines Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Prostate Cancer Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Prostate Cancer Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prostate Cancer Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Vaccines as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prostate Cancer Vaccines Sales by Region (2017-2022) & (K Units)
Table 16. Global Prostate Cancer Vaccines Sales Market Share by Region (2017-2022)
Table 17. Global Prostate Cancer Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Prostate Cancer Vaccines Revenue Market Share by Region (2017-2022)
Table 19. North America Prostate Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 20. North America Prostate Cancer Vaccines Sales Market Share by Country (2017-2022)
Table 21. North America Prostate Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Prostate Cancer Vaccines Revenue Market Share by Country (2017-2022)
Table 23. Europe Prostate Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 24. Europe Prostate Cancer Vaccines Sales Market Share by Country (2017-2022)
Table 25. Europe Prostate Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Prostate Cancer Vaccines Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Prostate Cancer Vaccines Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Prostate Cancer Vaccines Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Prostate Cancer Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Prostate Cancer Vaccines Revenue Market Share by Region (2017-2022)
Table 31. Latin America Prostate Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Prostate Cancer Vaccines Sales Market Share by Country (2017-2022)
Table 33. Latin America Prostate Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Prostate Cancer Vaccines Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Prostate Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Prostate Cancer Vaccines Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Prostate Cancer Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Prostate Cancer Vaccines Revenue Market Share by Country (2017-2022)
Table 39. Global Prostate Cancer Vaccines Sales by Type (2017-2022) & (K Units)
Table 40. Global Prostate Cancer Vaccines Sales Market Share by Type (2017-2022)
Table 41. Global Prostate Cancer Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Prostate Cancer Vaccines Revenue Share by Type (2017-2022)
Table 43. Global Prostate Cancer Vaccines Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Prostate Cancer Vaccines Sales (K Units) by Application (2017-2022)
Table 45. Global Prostate Cancer Vaccines Sales Market Share by Application (2017-2022)
Table 46. Global Prostate Cancer Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Prostate Cancer Vaccines Revenue Share by Application (2017-2022)
Table 48. Global Prostate Cancer Vaccines Price by Application (2017-2022) & (US$/Unit)
Table 49. Dendreon Corporation Corporation Information
Table 50. Dendreon Corporation Description and Business Overview
Table 51. Dendreon Corporation Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Dendreon Corporation Prostate Cancer Vaccines Product
Table 53. Dendreon Corporation Recent Developments/Updates
Table 54. Bavarian Nordic Corporation Information
Table 55. Bavarian Nordic Description and Business Overview
Table 56. Bavarian Nordic Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Bavarian Nordic Prostate Cancer Vaccines Product
Table 58. Bavarian Nordic Recent Developments/Updates
Table 59. Advantagene Corporation Information
Table 60. Advantagene Description and Business Overview
Table 61. Advantagene Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Advantagene Prostate Cancer Vaccines Product
Table 63. Advantagene Recent Developments/Updates
Table 64. OncBioMune Pharmaceuticals Corporation Information
Table 65. OncBioMune Pharmaceuticals Description and Business Overview
Table 66. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product
Table 68. OncBioMune Pharmaceuticals Recent Developments/Updates
Table 69. Advaxis immunotherapies Corporation Information
Table 70. Advaxis immunotherapies Description and Business Overview
Table 71. Advaxis immunotherapies Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Advaxis immunotherapies Prostate Cancer Vaccines Product
Table 73. Advaxis immunotherapies Recent Developments/Updates
Table 74. SOTIO Corporation Information
Table 75. SOTIO Description and Business Overview
Table 76. SOTIO Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. SOTIO Prostate Cancer Vaccines Product
Table 78. SOTIO Recent Developments/Updates
Table 79. Cleveland BioLabs Inc. Corporation Information
Table 80. Cleveland BioLabs Inc. Description and Business Overview
Table 81. Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Cleveland BioLabs Inc. Prostate Cancer Vaccines Product
Table 83. Cleveland BioLabs Inc. Recent Developments/Updates
Table 84. Curevac AG Corporation Information
Table 85. Curevac AG Description and Business Overview
Table 86. Curevac AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Curevac AG Prostate Cancer Vaccines Product
Table 88. Curevac AG Recent Developments/Updates
Table 89. Mediolanum Farmaceutici Corporation Information
Table 90. Mediolanum Farmaceutici Description and Business Overview
Table 91. Mediolanum Farmaceutici Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Mediolanum Farmaceutici Prostate Cancer Vaccines Product
Table 93. Mediolanum Farmaceutici Recent Developments/Updates
Table 94. Pfizer Inc. Corporation Information
Table 95. Pfizer Inc. Description and Business Overview
Table 96. Pfizer Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Pfizer Inc. Prostate Cancer Vaccines Product
Table 98. Pfizer Inc. Recent Developments/Updates
Table 99. Vaccitech Corporation Information
Table 100. Vaccitech Description and Business Overview
Table 101. Vaccitech Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Vaccitech Prostate Cancer Vaccines Product
Table 103. Vaccitech Recent Developments/Updates
Table 104. Sensei Biotherapeutics Corporation Information
Table 105. Sensei Biotherapeutics Description and Business Overview
Table 106. Sensei Biotherapeutics Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Sensei Biotherapeutics Prostate Cancer Vaccines Product
Table 108. Sensei Biotherapeutics Recent Developments/Updates
Table 109. Medigene AG Corporation Information
Table 110. Medigene AG Description and Business Overview
Table 111. Medigene AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Medigene AG Prostate Cancer Vaccines Product
Table 113. Medigene AG Recent Developments/Updates
Table 114. Ultimovacs Corporation Information
Table 115. Ultimovacs Description and Business Overview
Table 116. Ultimovacs Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Ultimovacs Prostate Cancer Vaccines Product
Table 118. Ultimovacs Recent Developments/Updates
Table 119. Oncovir Inc. Corporation Information
Table 120. Oncovir Inc. Description and Business Overview
Table 121. Oncovir Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Oncovir Inc. Prostate Cancer Vaccines Product
Table 123. Oncovir Inc. Recent Developments/Updates
Table 124. UbiVac Corporation Information
Table 125. UbiVac Description and Business Overview
Table 126. UbiVac Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. UbiVac Prostate Cancer Vaccines Product
Table 128. UbiVac Recent Developments/Updates
Table 129. Momotaro-Gene Inc. Corporation Information
Table 130. Momotaro-Gene Inc. Description and Business Overview
Table 131. Momotaro-Gene Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Momotaro-Gene Inc. Prostate Cancer Vaccines Product
Table 133. Momotaro-Gene Inc. Recent Developments/Updates
Table 134. Vaccibody AS Corporation Information
Table 135. Vaccibody AS Description and Business Overview
Table 136. Vaccibody AS Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Vaccibody AS Prostate Cancer Vaccines Product
Table 138. Vaccibody AS Recent Developments/Updates
Table 139. AlphaVax Inc. Corporation Information
Table 140. AlphaVax Inc. Description and Business Overview
Table 141. AlphaVax Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. AlphaVax Inc. Prostate Cancer Vaccines Product
Table 143. AlphaVax Inc. Recent Developments/Updates
Table 144. Production Base and Market Concentration Rate of Raw Material
Table 145. Key Suppliers of Raw Materials
Table 146. Prostate Cancer Vaccines Distributors List
Table 147. Prostate Cancer Vaccines Customers List
Table 148. Prostate Cancer Vaccines Market Trends
Table 149. Prostate Cancer Vaccines Market Drivers
Table 150. Prostate Cancer Vaccines Market Challenges
Table 151. Prostate Cancer Vaccines Market Restraints
Table 152. Global Prostate Cancer Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 153. Global Prostate Cancer Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 154. Global Prostate Cancer Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 155. Global Prostate Cancer Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 156. Global Prostate Cancer Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 157. Global Prostate Cancer Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 158. Global Prostate Cancer Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 159. Global Prostate Cancer Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 160. Global Prostate Cancer Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 161. Global Prostate Cancer Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 162. Global Prostate Cancer Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 163. Global Prostate Cancer Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prostate Cancer Vaccines
Figure 2. Global Prostate Cancer Vaccines Market Share by Type in 2021 & 2028
Figure 3. Tablet Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Prostate Cancer Vaccines Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global Prostate Cancer Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Prostate Cancer Vaccines Market Size (2017-2028) & (US$ Million)
Figure 11. Global Prostate Cancer Vaccines Sales (2017-2028) & (K Units)
Figure 12. Prostate Cancer Vaccines Sales Share by Manufacturers in 2021
Figure 13. Global Prostate Cancer Vaccines Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Prostate Cancer Vaccines Players: Market Share by Revenue in 2021
Figure 15. Prostate Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Prostate Cancer Vaccines Sales Market Share by Region (2017-2022)
Figure 17. Global Prostate Cancer Vaccines Sales Market Share by Region in 2021
Figure 18. Global Prostate Cancer Vaccines Revenue Market Share by Region (2017-2022)
Figure 19. Global Prostate Cancer Vaccines Revenue Market Share by Region in 2021
Figure 20. United States Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Prostate Cancer Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Prostate Cancer Vaccines by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Prostate Cancer Vaccines
Figure 44. Manufacturing Process Analysis of Prostate Cancer Vaccines
Figure 45. Prostate Cancer Vaccines Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed